Do analysts recommend MJN or TLRY?

Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 186.64%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Cronos Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better valuation and earnings, MJN or TLRY?

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group N/A N/A N/A N/A N/A Tilray Brands C$963.10M 0.71 -C$183.24M -C$1.41 N/A

Which has preferable earnings & valuation, CRON or TLRY?

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group C$179.09M 9.34 -C$32.78M C$0.19 23.89 Tilray Brands C$963.10M 0.71 -C$183.24M -C$1.41 N/A

Do analysts prefer TLRY or CARA?

Tilray Brands currently has a consensus price target of C$13.30, indicating a potential upside of 186.64%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Cara Operations. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, TLRY or CARA?

Cara Operations has lower revenue, but higher earnings than Tilray Brands. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tilray Brands C$963.10M 0.71 -C$183.24M -C$1.41 N/A Cara Operations N/A N/A N/A N/A N/A

Does the media prefer TLRY or GUD?

In the previous week, Tilray Brands had 3 more articles in the media than Knight Therapeutics. MarketBeat recorded 4 mentions for Tilray Brands and 1 mentions for Knight Therapeutics. Knight Therapeutics' average media sentiment score of 0.32 beat Tilray Brands' score of 0.03 indicating that Knight Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tilray Brands 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Knight Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Tilray Brands (TLRY) Competitors

C$4.57 -0.07 (-1.51%)

As of 11:46 AM Eastern

Compare

TLRY vs. MJN, CRON, CARA, GUD, and DHT.UN

Should you buy Tilray Brands stock or one of its competitors? Tilray Brands's main competitors and comparable companies include Cronos Group (MJN), Cronos Group (CRON), Cara Operations (CARA), Knight Therapeutics (GUD), and DRI Healthcare Trust (DHT.UN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Tilray Brands compare to Cronos Group?

Cronos Group (CVE:MJN) and Tilray Brands (TSE:TLRY) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment and earnings.

Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 186.64%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Tilray Brands had 4 more articles in the media than Cronos Group. MarketBeat recorded 4 mentions for Tilray Brands and 0 mentions for Cronos Group. Tilray Brands' average media sentiment score of 0.03 beat Cronos Group's score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company	Overall Sentiment
Cronos Group	Neutral
Tilray Brands	Neutral

4.4% of Tilray Brands shares are held by institutional investors. 0.7% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Cronos Group has a net margin of 0.00% compared to Tilray Brands' net margin of -18.92%. Cronos Group's return on equity of 0.00% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	N/A	N/A	N/A
Tilray Brands	-18.92%	-11.41%	-1.41%

Cronos Group has higher earnings, but lower revenue than Tilray Brands.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	N/A	N/A	N/A	N/A	N/A
Tilray Brands	C$963.10M	0.71	-C$183.24M	-C$1.41	N/A

Summary

Tilray Brands beats Cronos Group on 7 of the 10 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Cronos Group (TSE:CRON) and Tilray Brands (TSE:TLRY) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, media sentiment, risk and earnings.

Company	Overall Sentiment
Cronos Group	Neutral
Tilray Brands	Neutral

Cronos Group has a net margin of 38.95% compared to Tilray Brands' net margin of -18.92%. Cronos Group's return on equity of 6.46% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	38.95%	6.46%	-3.73%
Tilray Brands	-18.92%	-11.41%	-1.41%

Cronos Group currently has a consensus target price of C$4.92, suggesting a potential upside of 8.30%. Tilray Brands has a consensus target price of C$13.30, suggesting a potential upside of 186.64%. Given Tilray Brands' higher probable upside, analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cronos Group has a beta of 1.288385, meaning that its stock price is 29% more volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.261139, meaning that its stock price is 226% more volatile than the broader market.

4.4% of Cronos Group shares are held by institutional investors. Comparatively, 4.4% of Tilray Brands shares are held by institutional investors. 46.4% of Cronos Group shares are held by insiders. Comparatively, 0.7% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$179.09M	9.34	-C$32.78M	C$0.19	23.89
Tilray Brands	C$963.10M	0.71	-C$183.24M	-C$1.41	N/A

Summary

Cronos Group beats Tilray Brands on 10 of the 16 factors compared between the two stocks.

How does Tilray Brands compare to Cara Operations?

Tilray Brands (TSE:TLRY) and Cara Operations (TSE:CARA) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Cara Operations has lower revenue, but higher earnings than Tilray Brands.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$963.10M	0.71	-C$183.24M	-C$1.41	N/A
Cara Operations	N/A	N/A	N/A	N/A	N/A

4.4% of Tilray Brands shares are held by institutional investors. 0.7% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Tilray Brands had 4 more articles in the media than Cara Operations. MarketBeat recorded 4 mentions for Tilray Brands and 0 mentions for Cara Operations. Tilray Brands' average media sentiment score of 0.03 beat Cara Operations' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the media.

Company	Overall Sentiment
Tilray Brands	Neutral
Cara Operations	Neutral

Cara Operations has a net margin of 0.00% compared to Tilray Brands' net margin of -18.92%. Cara Operations' return on equity of 0.00% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-18.92%	-11.41%	-1.41%
Cara Operations	N/A	N/A	N/A

Tilray Brands currently has a consensus price target of C$13.30, indicating a potential upside of 186.64%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Cara Operations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Tilray Brands beats Cara Operations on 7 of the 10 factors compared between the two stocks.

How does Tilray Brands compare to Knight Therapeutics?

Tilray Brands (TSE:TLRY) and Knight Therapeutics (TSE:GUD) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

In the previous week, Tilray Brands had 3 more articles in the media than Knight Therapeutics. MarketBeat recorded 4 mentions for Tilray Brands and 1 mentions for Knight Therapeutics. Knight Therapeutics' average media sentiment score of 0.32 beat Tilray Brands' score of 0.03 indicating that Knight Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Knight Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Tilray Brands has a beta of 3.261139, suggesting that its stock price is 226% more volatile than the broader market. Comparatively, Knight Therapeutics has a beta of -0.449151, suggesting that its stock price is 145% less volatile than the broader market.

4.4% of Tilray Brands shares are held by institutional investors. Comparatively, 22.8% of Knight Therapeutics shares are held by institutional investors. 0.7% of Tilray Brands shares are held by company insiders. Comparatively, 45.6% of Knight Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Knight Therapeutics has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Knight Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$963.10M	0.71	-C$183.24M	-C$1.41	N/A
Knight Therapeutics	C$547.31M	1.92	-C$30.73M	C$0.15	71.20

Knight Therapeutics has a net margin of 2.72% compared to Tilray Brands' net margin of -18.92%. Knight Therapeutics' return on equity of 1.91% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-18.92%	-11.41%	-1.41%
Knight Therapeutics	2.72%	1.91%	0.51%

Tilray Brands currently has a consensus target price of C$13.30, indicating a potential upside of 186.64%. Knight Therapeutics has a consensus target price of C$9.50, indicating a potential downside of 11.05%. Given Tilray Brands' higher possible upside, analysts plainly believe Tilray Brands is more favorable than Knight Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Knight Therapeutics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Knight Therapeutics beats Tilray Brands on 12 of the 16 factors compared between the two stocks.

How does Tilray Brands compare to DRI Healthcare Trust?

DRI Healthcare Trust (TSE:DHT.UN) and Tilray Brands (TSE:TLRY) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends.

In the previous week, Tilray Brands had 4 more articles in the media than DRI Healthcare Trust. MarketBeat recorded 4 mentions for Tilray Brands and 0 mentions for DRI Healthcare Trust. Tilray Brands' average media sentiment score of 0.03 beat DRI Healthcare Trust's score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company	Overall Sentiment
DRI Healthcare Trust	Neutral
Tilray Brands	Neutral

DRI Healthcare Trust has higher earnings, but lower revenue than Tilray Brands. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DRI Healthcare Trust	C$172.34M	5.79	C$9.73M	-C$0.80	N/A
Tilray Brands	C$963.10M	0.71	-C$183.24M	-C$1.41	N/A

DRI Healthcare Trust presently has a consensus price target of C$25.60, indicating a potential upside of 40.89%. Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 186.64%. Given Tilray Brands' higher probable upside, analysts clearly believe Tilray Brands is more favorable than DRI Healthcare Trust.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DRI Healthcare Trust	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

DRI Healthcare Trust has a net margin of 5.02% compared to Tilray Brands' net margin of -18.92%. DRI Healthcare Trust's return on equity of 2.06% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DRI Healthcare Trust	5.02%	2.06%	4.22%
Tilray Brands	-18.92%	-11.41%	-1.41%

0.8% of DRI Healthcare Trust shares are held by institutional investors. Comparatively, 4.4% of Tilray Brands shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by company insiders. Comparatively, 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

DRI Healthcare Trust has a beta of 0.096953, indicating that its share price is 90% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.261139, indicating that its share price is 226% more volatile than the broader market.

Summary

DRI Healthcare Trust beats Tilray Brands on 9 of the 17 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TLRY vs. The Competition

Export

Metric	Tilray Brands	Pharmaceuticals Industry	Healthcare Sector	TSE Exchange
Market Cap	C$675.39M	C$12.43B	C$7.28B	C$12.63B
Dividend Yield	N/A	2.63%	2.51%	6.34%
P/E Ratio	-3.24	807.81	275.44	37.52
Price / Sales	0.70	748.21	559.80	8.41
Price / Cash	5.95	86.65	77.16	82.29
Price / Book	0.38	9.19	10.66	4.36
Net Income	-C$183.24M	C$2.84B	C$3.50B	C$299.09M
7 Day Performance	-14.10%	-3.85%	-3.65%	-0.27%
1 Month Performance	-20.10%	-7.95%	-8.06%	-2.32%
1 Year Performance	-79.51%	-5.71%	2.58%	14.22%

Tilray Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
TLRY Tilray Brands	1.5454 of 5 stars	C$4.57 -1.5%	C$13.30 +191.0%	-80.6%	C$675.39M	C$963.10M	N/A	3,595
MJN Cronos Group	N/A	C$12.15 -1.9%	N/A	+0.0%	C$1.73B	N/A	N/A	7,600
CRON Cronos Group	1.7158 of 5 stars	C$4.62 -1.1%	C$4.92 +6.4%	+29.0%	C$1.70B	C$179.09M	24.32	610
CARA Cara Operations	N/A	N/A	N/A	N/A	C$1.62B	N/A	N/A	80
GUD Knight Therapeutics	0.5858 of 5 stars	C$10.71 +1.6%	C$9.50 -11.3%	+85.1%	C$1.05B	C$547.31M	71.40	830

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:TLRY) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tilray Brands (TLRY) Competitors

TLRY vs. MJN, CRON, CARA, GUD, and DHT.UN

How does Tilray Brands compare to Cronos Group?

Summary

How does Tilray Brands compare to Cronos Group?

Summary

How does Tilray Brands compare to Cara Operations?

Summary

How does Tilray Brands compare to Knight Therapeutics?

Summary

How does Tilray Brands compare to DRI Healthcare Trust?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tilray Brands (TLRY) Competitors

TLRY vs. MJN, CRON, CARA, GUD, and DHT.UN

How does Tilray Brands compare to Cronos Group?

Do analysts recommend MJN or TLRY?

Does the media favor MJN or TLRY?

Do insiders and institutionals have more ownership in MJN or TLRY?

Is MJN or TLRY more profitable?

Which has better valuation and earnings, MJN or TLRY?

Summary

How does Tilray Brands compare to Cronos Group?

Does the media refer more to CRON or TLRY?

Is CRON or TLRY more profitable?

Do analysts prefer CRON or TLRY?

Which has more risk and volatility, CRON or TLRY?

Do insiders & institutionals have more ownership in CRON or TLRY?

Which has preferable earnings & valuation, CRON or TLRY?

Summary

How does Tilray Brands compare to Cara Operations?

Which has higher valuation & earnings, TLRY or CARA?

Do insiders and institutionals believe in TLRY or CARA?

Does the media refer more to TLRY or CARA?

Is TLRY or CARA more profitable?

Do analysts prefer TLRY or CARA?

Summary

How does Tilray Brands compare to Knight Therapeutics?

Does the media prefer TLRY or GUD?

Which has more risk & volatility, TLRY or GUD?

Do insiders & institutionals believe in TLRY or GUD?

Which has higher earnings & valuation, TLRY or GUD?

Is TLRY or GUD more profitable?

Do analysts rate TLRY or GUD?

Summary

How does Tilray Brands compare to DRI Healthcare Trust?

Does the media refer more to DHT.UN or TLRY?

Which has preferable valuation & earnings, DHT.UN or TLRY?

Do analysts recommend DHT.UN or TLRY?

Is DHT.UN or TLRY more profitable?

Do institutionals & insiders believe in DHT.UN or TLRY?

Which has more volatility and risk, DHT.UN or TLRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools